Navigation Links
Growth hormone's link to starvation may be clue to increasing life span, researchers find
Date:6/27/2008

DALLAS June 27, 2008 Researchers at UT Southwestern Medical Center have determined that starvation blocks the effects of growth hormone via a mechanism that may have implications in treating diabetes and extending life span.

"It's been well-established that growth is blunted during starvation. But our work shows that this is not just from running out of energy. It's much more sophisticated than that," said Dr. Steven Kliewer, professor of molecular biology and senior author of a study available online and appearing in today's issue of the journal Cell Metabolism.

Using genetically altered mice, the researchers found that during fasting, the actions of growth hormone are blocked by a fat-burning hormone called FGF21.

"It's something that we hadn't anticipated," said Dr. Kliewer.

Growth hormone has many functions in the growth and reproduction of cells, such as controlling the length of developing arm and leg bones in children.

Growth hormone has several other functions, however, even in adults. It promotes the breakdown of fats, stimulates creation of protein and increases levels of IGF-1 (insulin-like growth factor-1), a hormone that promotes growth. Too much growth hormone can cause insulin resistance, resulting in diabetes, and lead to other disorders.

In the current study, mice that were genetically altered to produce excess FGF21 grew to be much smaller than ordinary mice, even though they ate more and had more fat in proportion to their size.

Paradoxically, and to the researchers' surprise, the altered, smaller mice produced much greater amounts of growth hormone than normal.

Why didn't the altered mice grow larger than normal in response? The researchers found that FGF21 does not block the production of growth hormone; rather, it works to prevent growth hormone from activating the genes it normally controls.

Interfering with the actions of growth hormone has been shown to increase life span in mice, Dr. Kliewer said.

"In addition, intermittent fasting which increases FGF21 concentrations also extends life span in mice. This raises the intriguing possibility that FGF21 might be a longevity factor," Dr. Kliewer said.

"This is something that we're beginning to test in the lab," he said. "But our genetically engineered mice have all the classic hallmarks of extended life span: growth hormone resistance, low concentrations of IGF-1, increased insulin sensitivity and small size."

FGF21 is already being tested in human clinical trials for treatment of obesity and diabetes in adults, but the new findings linking FGF21 to interference with growth hormone might indicate that caution is needed before using it in children or teens, Dr. Kliewer said.


'/>"/>

Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related biology news :

1. Blue light used to harden tooth fillings stunts tumor growth
2. Scientists find potential protein biomarkers for growth hormone
3. Synthetic cocoa chemical slows growth of tumors in human cell lines
4. NYU dental professor discovers biological clock linking tooth growth to other metabolic processes
5. T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role
6. Faster koa tree growth without adverse ecosystem effects
7. Popular apple variety harbors unusual cell growth
8. Yale scientists show that a microRNA can reduce lung cancer growth
9. New UC analysis shows alarming increase in expected growth of Chinas carbon dioxide emissions
10. Alarming growth in expected CO2 emissions in China, finds UC analysis
11. A compound extracted from olives inhibits cancer cells growth and prevents their appearance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Growth hormone's link to starvation may be clue to increasing life span, researchers find
(Date:1/3/2017)... VEGAS , Jan. 3, 2017 Onitor, ... the introduction of Onitor Track, an innovative biometric data-driven ... men, showcasing this month at the 2017 Consumer Electronics ... In the U.S., the World Health ... more than two-thirds of adults who are overweight or ...
(Date:12/20/2016)... 20, 2016   Valencell , the leading ... STMicroelectronics (NYSE: STM), a global semiconductor leader ... announced today the launch of a new, highly ... that includes ST,s compact SensorTile turnkey ... biometric sensor system. Together, SensorTile and Benchmark deliver ...
(Date:12/16/2016)... The global wearable medical device market, in terms of ... USD 5.31 billion in 2016, at a CAGR of 18.0% during ... ... in medical devices, launch of a growing number of smartphone-based healthcare ... healthcare providers, and increasing focus on physical fitness. ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... , January 20, 2017 ... is one of leading causes of death worldwide. There ... the number of cancer related deaths increased gradually over ... in incidence rate of various cancers continues to drive ... research report by Global Market Insights, Inc. cancer biological ...
(Date:1/19/2017)... Research Future has a half cooked research report on Global Liquid ... and expected to reach USD 450 Million by the end of ... ... assessed as a swiftly growing market and expected that the market ... There has been a tremendous growth in the prevalence of cancer ...
(Date:1/19/2017)... and Markets ... addition of the "Implantable Biomaterials Market Analysis & ... to their offering. Report Highlights: ... current and future market trends to identify the investment opportunities ... numbers Key market trends across the business segments, Regions ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 /PRNewswire/ ... a privately-held immunotherapeutics company targeting infectious diseases, announced ... the merger of PharmAthene and Altimmune in an ... Fund, HealthCap, Truffle Capital and Redmont Capital. The ... immunotherapeutics company with four clinical stage and one ...
Breaking Biology Technology: